LARYS MED: what changed
LARYS MED
Largest movements
- Current investments +€23,707
up €23,707 (+64.9%), from €36,501 to €60,207
- Receivables within one year +€8,942
up €8,942 (+101%), from €8,897 to €17,839
of which Other amounts receivable: +€8,670
- Cash -€5,778
down €5,778 (-41.1%), from €14,052 to €8,275
mainly Current investments (-€23,707) and Receivables within one year (-€8,942)
- Tangible fixed assets -€4,953
down €4,953 (-63.3%), from €7,830 to €2,877
- Profit (loss) carried forward +€26,851
up €26,851 (+47.4%), from €56,632 to €83,483
- Other debts -€2,155
down €2,155 (-71.5%), from €3,014 to €859
- Tax, wage and social debts -€2,047
down €2,047 (-73.3%), from €2,793 to €746
- Gross operating margin -€5,561
down €5,561 (-11.7%), from €47,524 to €41,963
- Taxes -€748
down €748 (-8.2%), from €9,113 to €8,365
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €69,006 | €91,112 | +€22,105 | +32.0% |
| Fixed assets | 21/28 | €7,830 | €2,877 | -€4,953 | -63.3% |
| Tangible fixed assets | 22/27 | €7,830 | €2,877 | -€4,953 | -63.3% |
| Furniture and vehicles | 24 | €7,830 | €2,877 | -€4,953 | -63.3% |
| Current assets | 29/58 | €61,176 | €88,234 | +€27,058 | +44.2% |
| Amounts receivable within one year | 40/41 | €8,897 | €17,839 | +€8,942 | +101% |
| Trade receivables | 40 | €8,480 | €8,752 | +€272 | +3.2% |
| Other amounts receivable | 41 | €417 | €9,087 | +€8,670 | +2,079% |
| Current investments | 50/53 | €36,501 | €60,207 | +€23,707 | +64.9% |
| Cash at bank and in hand | 54/58 | €14,052 | €8,275 | -€5,778 | -41.1% |
| Deferred charges and accrued income | 490/1 | €1,727 | €1,914 | +€187 | +10.8% |
| Total equity and liabilities | 10/49 | €69,006 | €91,112 | +€22,105 | +32.0% |
| Equity | 10/15 | €59,632 | €86,483 | +€26,851 | +45.0% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €56,632 | €83,483 | +€26,851 | +47.4% |
| Amounts payable | 17/49 | €9,375 | €4,628 | -€4,746 | -50.6% |
| Amounts payable within one year | 42/48 | €9,375 | €4,628 | -€4,746 | -50.6% |
| Trade debts | 44 | €3,567 | €3,024 | -€543 | -15.2% |
| Suppliers | 440/4 | €3,567 | €3,024 | -€543 | -15.2% |
| Taxes, remuneration and social security | 45 | €2,793 | €746 | -€2,047 | -73.3% |
| Taxes | 450/3 | €2,793 | €746 | -€2,047 | -73.3% |
| Other amounts payable | 47/48 | €3,014 | €859 | -€2,155 | -71.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,951 | €5,993 | +€42 | +0.7% |
| Other operating charges | 640/8 | €895 | €450 | -€444 | -49.7% |
| Gross operating margin | 9900 | €47,524 | €41,963 | -€5,561 | -11.7% |
| Operating profit (loss) | 9901 | €40,678 | €35,520 | -€5,158 | -12.7% |
| Financial income | 75/76B | €255 | €705 | +€449 | +176% |
| Recurring financial income | 75 | €255 | €705 | +€449 | +176% |
| Financial charges | 65/66B | €67 | €150 | +€82 | +123% |
| Recurring financial charges | 65 | €67 | €150 | +€82 | +123% |
| Profit (loss) for the period before taxes | 9903 | €40,866 | €36,075 | -€4,791 | -11.7% |
| Income taxes | 67/77 | €9,113 | €8,365 | -€748 | -8.2% |
| Profit (loss) for the period | 9904 | €31,753 | €27,710 | -€4,043 | -12.7% |
| Profit (loss) for the period to be appropriated | 9905 | €31,753 | €27,710 | -€4,043 | -12.7% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.